Thus, the goal of the current work was to investigate the functions of miRNAs that preserve immunological homeostasis by controlling the development of CD4+IL-10+ T cells, and consequently clinically reduce AAA lesions. The gene discussed is CD4; the disease is triple-A syndrome.